GW406381

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GW406381, covering 2009-02-23 to 2017-01-19. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee [Phase 3]